Hereditary spastic paraplegia in Mali : epidemiological and clinical features
© 2022. The Author(s) under exclusive licence to Belgian Neurological Society..
BACKGROUND AND PURPOSE: Hereditary spastic paraplegia (HSP) is a group of neurodegenerative diseases divided into pure and complex forms, with spasticity in lower limbs only, or associated with other neurologic and non-neurologic manifestations, respectively. Although widely reported in other populations, very little data exist in sub-Saharan Africa.
METHODS: Patients with neurodegenerative features were evaluated over a 19-month period at the Department of Neurology, Teaching Hospital of Point "G", Bamako, Mali. The diagnosis of HSP was considered based on family history and the absence of other known non-genetic causes. Genetic analysis including candidate gene and whole exome sequencing was performed and variant pathogenicity was tested using prediction tools and ACMG guidelines.
RESULTS: Of the 170 families with hereditary neurological disorders enrolled, 16 had features consistent with HSP, a frequency of 9%. The average age of onset was 14.7 years with 46% starting before age 6. The male/female ratio was 2.6:1. Complex forms were seen in 75% of cases, and pure forms in 25%. Pyramidal findings were present in all patients. Associated features included mental retardation, peripheral neuropathy, epilepsy, oculomotor impairment and urinary urgency. Most patients were treated with a muscle relaxant and physical therapy, and restorative surgery was done in one. Genetic testing identified novel variants in three families (19%).
CONCLUSION: This study confirms the clinical variability of HSPs and adds African data to the current literature.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:123 |
|---|---|
| Enthalten in: |
Acta neurologica Belgica - 123(2023), 6 vom: 17. Dez., Seite 2155-2165 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Diarra, Salimata [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinical features |
|---|
| Anmerkungen: |
Date Completed 29.11.2023 Date Revised 29.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s13760-022-02113-w |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM349101655 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM349101655 | ||
| 003 | DE-627 | ||
| 005 | 20231226041824.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s13760-022-02113-w |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1163.xml |
| 035 | |a (DE-627)NLM349101655 | ||
| 035 | |a (NLM)36396882 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Diarra, Salimata |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hereditary spastic paraplegia in Mali |b epidemiological and clinical features |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.11.2023 | ||
| 500 | |a Date Revised 29.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. The Author(s) under exclusive licence to Belgian Neurological Society. | ||
| 520 | |a BACKGROUND AND PURPOSE: Hereditary spastic paraplegia (HSP) is a group of neurodegenerative diseases divided into pure and complex forms, with spasticity in lower limbs only, or associated with other neurologic and non-neurologic manifestations, respectively. Although widely reported in other populations, very little data exist in sub-Saharan Africa | ||
| 520 | |a METHODS: Patients with neurodegenerative features were evaluated over a 19-month period at the Department of Neurology, Teaching Hospital of Point "G", Bamako, Mali. The diagnosis of HSP was considered based on family history and the absence of other known non-genetic causes. Genetic analysis including candidate gene and whole exome sequencing was performed and variant pathogenicity was tested using prediction tools and ACMG guidelines | ||
| 520 | |a RESULTS: Of the 170 families with hereditary neurological disorders enrolled, 16 had features consistent with HSP, a frequency of 9%. The average age of onset was 14.7 years with 46% starting before age 6. The male/female ratio was 2.6:1. Complex forms were seen in 75% of cases, and pure forms in 25%. Pyramidal findings were present in all patients. Associated features included mental retardation, peripheral neuropathy, epilepsy, oculomotor impairment and urinary urgency. Most patients were treated with a muscle relaxant and physical therapy, and restorative surgery was done in one. Genetic testing identified novel variants in three families (19%) | ||
| 520 | |a CONCLUSION: This study confirms the clinical variability of HSPs and adds African data to the current literature | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Clinical features | |
| 650 | 4 | |a Frequency | |
| 650 | 4 | |a Genetic testing | |
| 650 | 4 | |a Hereditary spastic paraplegia | |
| 650 | 4 | |a Mali | |
| 700 | 1 | |a Coulibaly, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Dembélé, Kékouta |e verfasserin |4 aut | |
| 700 | 1 | |a Ngouth, Nyater |e verfasserin |4 aut | |
| 700 | 1 | |a Cissé, Lassana |e verfasserin |4 aut | |
| 700 | 1 | |a Diallo, Seybou H |e verfasserin |4 aut | |
| 700 | 1 | |a Ouologuem, Madani |e verfasserin |4 aut | |
| 700 | 1 | |a Diallo, Salimata |e verfasserin |4 aut | |
| 700 | 1 | |a Coulibaly, Oumar |e verfasserin |4 aut | |
| 700 | 1 | |a Bagayoko, Koumba |e verfasserin |4 aut | |
| 700 | 1 | |a Coulibaly, Dramane |e verfasserin |4 aut | |
| 700 | 1 | |a Simaga, Assiatou |e verfasserin |4 aut | |
| 700 | 1 | |a Sango, Hammadoun A |e verfasserin |4 aut | |
| 700 | 1 | |a Traoré, Mahamadou |e verfasserin |4 aut | |
| 700 | 1 | |a Jacobson, Steve |e verfasserin |4 aut | |
| 700 | 1 | |a Fischbeck, Kenneth H |e verfasserin |4 aut | |
| 700 | 1 | |a Landouré, Guida |e verfasserin |4 aut | |
| 700 | 1 | |a Guinto, Cheick O |e verfasserin |4 aut | |
| 700 | 0 | |a H3Africa consortium |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta neurologica Belgica |d 1970 |g 123(2023), 6 vom: 17. Dez., Seite 2155-2165 |w (DE-627)NLM000045705 |x 2240-2993 |7 nnns |
| 773 | 1 | 8 | |g volume:123 |g year:2023 |g number:6 |g day:17 |g month:12 |g pages:2155-2165 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s13760-022-02113-w |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 123 |j 2023 |e 6 |b 17 |c 12 |h 2155-2165 | ||